2000
DOI: 10.1046/j.1471-4159.2000.0750741.x
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis

Abstract: Extracellular levels of norepinephrine (NE) and glutamate (Glu) in the ventral bed nucleus of the stria terminalis (vBNST) of saline-and chronic morphine-treated rats, with or without withdrawal, were studied by means of the in vivo microdialysis technique in anesthetized rats. In addition, the tissue concentration of NE was studied at different rostrocaudal levels of the vBNST. Chronic morphine treatment significantly increased extracellular levels of NE, but not Glu, in vBNST. At 48 h after naloxone-induced … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
50
1
1

Year Published

2001
2001
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 70 publications
(58 citation statements)
references
References 62 publications
2
50
1
1
Order By: Relevance
“…The vBNST receives dense noradrenergic projections from the NTS (Forray and Gysling, 2004), and thus is a likely downstream target for norepinephrine's actions in morphine reward. However, we did not detect norepinephrine release in the vBNST during morphine, although elevated norepinephrine in the BNST may develop following chronic drug exposure (Fuentealba et al, 2000). Alternatively, NTS norepinephrine may instead modulate drug-reward through its projections to the NAc (Delfs et al, 1998) where it can regulate dopamine efflux, and presumably the rewarding property of abused drugs through α 1 receptors (Mitrano et al, 2012).…”
Section: Discussioncontrasting
confidence: 59%
See 1 more Smart Citation
“…The vBNST receives dense noradrenergic projections from the NTS (Forray and Gysling, 2004), and thus is a likely downstream target for norepinephrine's actions in morphine reward. However, we did not detect norepinephrine release in the vBNST during morphine, although elevated norepinephrine in the BNST may develop following chronic drug exposure (Fuentealba et al, 2000). Alternatively, NTS norepinephrine may instead modulate drug-reward through its projections to the NAc (Delfs et al, 1998) where it can regulate dopamine efflux, and presumably the rewarding property of abused drugs through α 1 receptors (Mitrano et al, 2012).…”
Section: Discussioncontrasting
confidence: 59%
“…Although few studies emphasize the noradrenergic component of drug use, norepinephrine in the bed nucleus of the stria terminalis (BNST) has been clearly implicated in drug withdrawal (Aston-Jones et al, 1999). The ventral BNST (vBNST) receives dense innervation from the nucleus of the solitary tract (NTS) (Forray and Gysling, 2004), the source of norepinephrine critical for withdrawal aversion , and chronic morphine treatment increases basal norepinephrine in the BNST (Fuentealba et al, 2000). However, no work addresses the effect of acute drug exposure or withdrawal on phasic release.…”
Section: Introductionmentioning
confidence: 99%
“…At least certain withdrawal signs involve activation of noradrenergic transmission in the BNST originating in the NTS and A1 (Aston-Jones et al, 1999;Delfs et al, 2000). In addition, an increase of noradrenergic extracellular levels in vBNST in morphinewithdrawn rats has been shown in vivo (Fuentealba et al, 2000). In view of these findings, we propose that clonidine pretreatment may prevent the withdrawal-induced increase of noradrenaline in the BNST, which may disinhibit the glutamatergic BNST projection to the VTA.…”
Section: Clonidine Modulates the Noradrenaline-dopamine Interaction Dmentioning
confidence: 77%
“…However, interactions between the two pathways remain poorly understood (De Vries and Shippenberg, 2002;Delfs et al, 2000;Gobbi et al, 2001;Harris and Aston-Jones, 1994;Maldonado, 1997). Withdrawal from chronic morphine is associated with opposite changes in noradrenergic and dopaminergic neuronal activities: noradrenergic neurons are activated and noradrenaline release is increased in the cortex and the bed nucleus of the stria terminalis (BNST) (Aghajanian, 1978;Akaoka and AstonJones, 1991;Fuentealba et al, 2000;Rossetti et al, 1993), and conversely ventral tegmental area dopaminergic (VTA DA) neurons are inhibited (Diana et al, 1995;Nowycky et al 1978) and DA release in the nucleus accumbens is consistently reduced (Acquas et al, 1991).…”
Section: Introductionmentioning
confidence: 99%
“…Retrograde tract-tracing studies in morphine-dependent rats after NTX-precipitated opiate withdrawal show that noradrenergic cells stimulated by opioid withdrawal and projecting to the BST are prominently located in the nucleus tractus solitarius (NTS) (Aston-Jones et al, 1999). As a consequence of the noradrenergic system activation, NE extracellular levels in the BST are elevated during withdrawal (Fuentealba et al, 2000) and produce an activation of the dorsolateral and ventral parts of the BST that is blockable by b antagonists (Aston-Jones et al, 1999; Gracy et al, 2001). We studied basal expression of several catecholamine-related molecules in the locus coeruleus and NTS of HR and LR animals (in preparation).…”
Section: Discussionmentioning
confidence: 99%